Industry News Archive

New Clinical Trial for Patients with Tumors Harboring NRG1 Fusions

New clinical trial in patients suffering from tumors harboring NRG1 gene alterations, specifically NRG1 gene fusion-positive advanced solid tumors. 

To learn more about a prospective real-world outcomes study in patients with tumors harboring NRG1 fusions, click here.

Posted on 12/09/2021.

1801 Research Boulevard Suite 400
Rockville, MD 20850
Tel: 301.984.9496 | Fax: 301.770.1949
txsco.com
Email Us